Shijiazhuang Yiling Pharmaceutical Co., Ltd.
SZSE:002603.SZ
21.72 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 10,318.313 | 12,532.841 | 10,116.794 | 8,782.48 | 5,825.294 | 4,814.558 | 4,081.267 | 3,820.159 | 3,184.752 | 2,921.157 | 2,490.162 | 1,648.676 | 1,953.211 | 1,649.32 | 1,632.331 | 938.556 |
| Kosten van de omzet
| 4,407.809 | 4,540.572 | 3,680.995 | 3,118.413 | 2,106.213 | 1,630.825 | 1,303.914 | 1,287.698 | 1,164.411 | 1,077.651 | 830.502 | 524.042 | 617.691 | 554.703 | 636.807 | 379.731 |
| Brutowinst
| 5,910.504 | 7,992.269 | 6,435.799 | 5,664.067 | 3,719.082 | 3,183.733 | 2,777.353 | 2,532.46 | 2,020.341 | 1,843.506 | 1,659.66 | 1,124.634 | 1,335.521 | 1,094.617 | 995.524 | 558.825 |
| Brutowinstmarge
| 0.573 | 0.638 | 0.636 | 0.645 | 0.638 | 0.661 | 0.681 | 0.663 | 0.634 | 0.631 | 0.666 | 0.682 | 0.684 | 0.664 | 0.61 | 0.595 |
| Onderzoek- en ontwikkelingskosten
| 853.187 | 1,032.006 | 792.163 | 654.389 | 390.746 | 316.71 | 217.441 | 187.725 | 154.631 | 139.748 | 139.379 | 111.051 | 82.174 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 185.71 | 158.242 | 165.913 | 166.585 | 114.6 | 83.054 | 59.963 | 56.646 | 101.8 | 71.997 | 66.513 | 58.45 | 34.223 | 153.59 | 101.907 | 76.818 |
| Verkoop- en marketingkosten
| 1,690.587 | 3,258.714 | 3,434.003 | 3,035.268 | 2,227.097 | 1,819.874 | 1,600.975 | 1,434.053 | 1,159.522 | 1,140.673 | 1,133.453 | 737.32 | 638.011 | 571.387 | 528.441 | 315.204 |
| Verkoop-, algemene en administratieve kosten
| 3,167.023 | 3,416.956 | 3,599.917 | 3,201.854 | 2,341.697 | 1,902.928 | 1,660.938 | 1,490.699 | 1,261.322 | 1,212.67 | 1,199.967 | 795.77 | 672.234 | 724.976 | 630.347 | 392.022 |
| Overige kosten
| 144.439 | 576.866 | 366.582 | 322.967 | 301.581 | -17.95 | -10.895 | 14.319 | 0.725 | 3.851 | 16.141 | 28.15 | 42.925 | 23.771 | 15.669 | -5.958 |
| Bedrijfskosten
| 4,130.676 | 5,025.829 | 4,758.661 | 4,179.209 | 3,034.024 | 2,499.486 | 2,144.141 | 1,904.01 | 1,541.873 | 1,462.316 | 1,424.781 | 975.482 | 846.671 | 747.463 | 650.546 | 404.608 |
| Bedrijfsresultaat
| 1,779.828 | 2,829.555 | 1,569.071 | 1,438.036 | 710.175 | 718.953 | 649.243 | 623.689 | 499.031 | 409.993 | 273.227 | 188.221 | 489.588 | 345.719 | 339.639 | 150.371 |
| Bedrijfsresultaat ratio
| 0.172 | 0.226 | 0.155 | 0.164 | 0.122 | 0.149 | 0.159 | 0.163 | 0.157 | 0.14 | 0.11 | 0.114 | 0.251 | 0.21 | 0.208 | 0.16 |
| Totaal overige inkomsten en kosten netto
| -95.616 | -48.912 | -15.353 | -15.564 | -2.29 | -17.95 | -10.856 | 3.363 | 0.358 | 0.566 | 16.113 | 28.015 | 42.916 | 23.043 | 14.674 | -6.136 |
| Inkomen voor belasting
| 1,684.211 | 2,780.643 | 1,553.718 | 1,422.472 | 707.885 | 701.004 | 638.347 | 637.691 | 499.39 | 410.56 | 289.34 | 216.236 | 532.504 | 368.761 | 354.313 | 144.235 |
| Inkomen voor belasting ratio
| 0.163 | 0.222 | 0.154 | 0.162 | 0.122 | 0.146 | 0.156 | 0.167 | 0.157 | 0.141 | 0.116 | 0.131 | 0.273 | 0.224 | 0.217 | 0.154 |
| Belastingkosten
| 339.909 | 423.821 | 212.086 | 207.541 | 104.841 | 108.049 | 101.562 | 101.765 | 72.585 | 56.064 | 45.049 | 30.43 | 78.433 | 53.736 | 56.798 | 21.983 |
| Nettowinst
| 1,352.379 | 2,362.756 | 1,343.856 | 1,218.738 | 606.501 | 599.222 | 540.705 | 542.023 | 430.491 | 354.495 | 244.291 | 185.806 | 454.071 | 315.559 | 297.183 | 122.117 |
| Nettowinstmarge
| 0.131 | 0.189 | 0.133 | 0.139 | 0.104 | 0.124 | 0.132 | 0.142 | 0.135 | 0.121 | 0.098 | 0.113 | 0.232 | 0.191 | 0.182 | 0.13 |
| WPA (Winst Per Aandeel)
| 0.81 | 1.41 | 0.8 | 0.73 | 0.36 | 0.36 | 0.32 | 0.34 | 0.28 | 0.23 | 0.16 | 0.12 | 0.32 | 0.26 | 0.25 | 0.1 |
| Verwaterde WPA
| 0.81 | 1.41 | 0.8 | 0.73 | 0.36 | 0.36 | 0.32 | 0.34 | 0.27 | 0.23 | 0.16 | 0.12 | 0.32 | 0.26 | 0.25 | 0.1 |
| EBITDA
| 2,286.657 | 3,283.125 | 1,957.213 | 1,709.733 | 978.163 | 960.905 | 896.719 | 870.871 | 646.717 | 466.733 | 353.371 | 285.921 | 597.888 | 420.839 | 388.449 | 175.708 |
| EBITDA ratio
| 0.222 | 0.269 | 0.199 | 0.201 | 0.167 | 0.199 | 0.217 | 0.224 | 0.198 | 0.16 | 0.143 | 0.175 | 0.316 | 0.256 | 0.242 | 0.19 |